• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Clinical ophthalmology >Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
【24h】

Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab

机译：用含有玻璃体内贝伐单抗治疗的脉络膜新生血管相关的血管血症

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Purpose: To report a rare case of central vision loss in a patient with choroideremia.Patients and methods: A retrospective, interventional case report.Results: A 13-year-old male with history of choroideremia presented with subacute loss of central acuity in his left eye. Examination and diagnostic testing revealed subretinal fibrosis secondary to a choroidal neovascular membrane (CNVM). A trial of anti-vascular endothelial growth factor (VEGF) therapy with the injection of intravitreal bevacizumab was attempted. Mild improvements in acuity and anatomy were noted.Conclusion: Choroideremia is a rare hereditary choroidal dystrophy that predominantly affects males in the first and second decades of life. Visual acuity is usually spared until later in life. CNVM is a rare manifestation of choroideremia with only a handful of case reports presented in the literature. This case is unique in that it is the first reported case that received treatment with intravitreal anti-VEGF therapy.
机译：目的：报告少女血症患者中的少数罕见的中央视力丧失。患者和方法：回顾性，介入案例报告。结果：一名13岁的男性，患有少女血症史上的中央敏锐症的历史左眼。检查和诊断检测显示脉络膜新血管膜（CNVM）中的次射流纤维化。试图用注射玻璃体玻璃纤维素注射抗血管内皮生长因子（VEGF）治疗的试验。注意到敏锐和解剖学的温和改善。结论：苦参堇是一种罕见的遗传性脉络膜营养不良症，主要影响着生命的第一个和第二十年的男性。视力通常在生命的晚些时候施用。 CNVM是少女血症的罕见表现，只有在文献中呈现出少数案例报告。这种情况是独特的，因为它是第一个接受玻璃体内抗VEGF治疗治疗的报告案例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号